Preventing VTE in the orthopedic surgical population: Part 2-dabigatran and rivaroxabanThe role of two new oral antithrombotic agents Intensive type 2 diabetes treatment fraught with dangerLow HbA1c levels and insulin-based therapy are linked with increased mortality in British database Can OMA/gov’t meet unattached patients goal? Study OKs dose boost for estrogen receptor antagonist Scoliosis treated by remote control Implantable rods can be lengthened without the need for further surgery Olympic training translates into a focused physician Risk of opioid addiction low for chronic pain patients However, proper screening for drug-abuse history and a balanced approach to pain management are important Statins benefit leukemia patients Clinical trials needed to pinpoint ideal candidates ‘Negation’ clawing back millions from Ontario doctors Capitated practices lost more than $1.7 million in 2008/09 when their patients went elsewhere for care. Mystery miscarriages not helped by anticoagulation Trial debunks treatment that has become popular for unexplained fetal loss despite lack of evidence First Previous 1612 1613 1614 1615 1616 Next Last
